Key facts
- It has raised $25.0M; the latest was Seed Round ($12.7M) in Mar 2026.
- Notable investors include Gates Foundation, QIC, AgriZeroNZ, Mandalay VC, Tenacious Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Nbryo
- ·The full record, as it builds
Funding rounds
No funding rounds for Nbryo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nbryo
Developer of cattle breeding technology designed for livestock industries to improve production efficiency. The company's technology identifies embryos of desired sex and breeding values and helps to improve the genetic profile of their stock through artificial insemination, enabling cattle breeding farmers to reduce the environmental impact of livestock production.
- Sector
- Materials and Resources
- HQ
- Brisbane, Australia
- Founded
- 2020
- Employees
- 22
- Website
- nbryo.com/
- Ownership
- Privately Held (backing)
Nbryo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nbryo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nbryo in its N-PORT filings yet. We sweep new filings monthly.